Diabetes drugs and weight loss - Mayo Clinic
Nov 14, 2024 · The first group is glucagon-like peptide 1 (GLP-1) agonists. The second is sodium glucose cotransporter 2 (SGLT-2) inhibitors. GLP-1 agonists GLP-1 agonists for type 2 …
GLP-1RA and thyroid cancer: New study suggests detection bias, …
Aug 21, 2025 · A Mayo Clinic study finds no overall increase in thyroid cancer risk with GLP-1RA therapy, suggesting early diagnoses likely reflect detection bias, not causation.
Medicamentos para la diabetes y pérdida de peso - Mayo Clinic
Apr 2, 2025 · Hay dos grupos principales de medicamentos para la diabetes tipo 2 que reducen la glucosa en la sangre y también pueden derivar en la pérdida de peso. En el primer grupo …
Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic
Oct 4, 2005 · Confused by all the treatment choices for type 2 diabetes? Use this guide to better understand the medicines available to help control blood sugar.
Management of obesity within hepatology clinics - Mayo Clinic
Dec 12, 2023 · Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and bariatric surgery in patients …
Diagnosis and management of patients with gastroparesis
Jan 25, 2022 · Other conditions and factors associated with gastroparesis include type 1 and type 2 diabetes mellitus, medications that impair gastric emptying (most notably opioids, GLP-1 …
Diabetic nephropathy (kidney disease) - Mayo Clinic
Oct 24, 2023 · Newer drugs include Metformin (Fortamet, Glumetza, others), glucagon-like peptide 1 (GLP-1) receptor agonists and SGLT2 inhibitors. Ask your health care professional if …
糖尿病药物与减重 - 妙佑医疗国际 - Mayo Clinic
Apr 4, 2025 · 除减重以外的益处 除了帮助控制血糖和促进减重外，GLP-1 激动剂和 SGLT-2 抑制剂似乎还有其他健康益处。 研究发现，其中一些药物可以降低某些严重健康状况的风险，例 …
Angiotensin-converting enzyme (ACE) inhibitors - Mayo Clinic
Mar 27, 2025 · Angiotensin-converting enzyme inhibitors, also called ACE inhibitors, are medicines that lower blood pressure. ACE inhibitors prevent an enzyme in the body from …
Semaglutide (oral route) - Side effects & dosage - Mayo Clinic
6 days ago · This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes who are at high risk for these events. Semaglutide is a glucagon …